Specifically, GLP-1s can increase the risk of hypoglycemia (low blood sugar) and SGLT-2s can raise the risk of a serious, life-threatening complication called diabetic ketoacidosis (DKA)
Newfoundland and Labrador: Learn more about MCP here
The trial demonstrated dose-dependent weight loss, with participants receiving 12 mg achieving a mean body weight reduction of approximately 24% over 48 weeks a result that has attracted considerable scientific and public interest
Among those with insurance, 30% reported that affording their share of GLP-1 costs was somewhat difficult, and 25% reported that it was very difficult
Book appointment online To receive further guidance on vitamin B12 injections, please book an appointment online with our experienced team at Chatham Pharmacy
The treatment for 24 weeks led to substantial reductions in liver fat content across all dosage levels, with a mean relative change from baseline of up to -82.4% for the highest dose